BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23613318)

  • 1. Biological and clinical relevance of miRNA expression signatures in primary plasma cell leukemia.
    Lionetti M; Musto P; Di Martino MT; Fabris S; Agnelli L; Todoerti K; Tuana G; Mosca L; Gallo Cantafio ME; Grieco V; Bianchino G; D'Auria F; Statuto T; Mazzoccoli C; De Luca L; Petrucci MT; Offidani M; Di Raimondo F; Falcone A; Caravita T; Omede' P; Morabito F; Tassone P; Boccadoro M; Palumbo A; Neri A
    Clin Cancer Res; 2013 Jun; 19(12):3130-42. PubMed ID: 23613318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles.
    Lionetti M; Agnelli L; Mosca L; Fabris S; Andronache A; Todoerti K; Ronchetti D; Deliliers GL; Neri A
    Genes Chromosomes Cancer; 2009 Jun; 48(6):521-31. PubMed ID: 19306352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional characterization of a prospective series of primary plasma cell leukemia revealed signatures associated with tumor progression and poorer outcome.
    Todoerti K; Agnelli L; Fabris S; Lionetti M; Tuana G; Mosca L; Lombardi L; Grieco V; Bianchino G; D'Auria F; Statuto T; Mazzoccoli C; De Luca L; Petrucci MT; Morabito F; Offidani M; Di Raimondo F; Falcone A; Omede' P; Tassone P; Boccadoro M; Palumbo A; Neri A; Musto P
    Clin Cancer Res; 2013 Jun; 19(12):3247-58. PubMed ID: 23599371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide analysis of primary plasma cell leukemia identifies recurrent imbalances associated with changes in transcriptional profiles.
    Mosca L; Musto P; Todoerti K; Barbieri M; Agnelli L; Fabris S; Tuana G; Lionetti M; Bonaparte E; Sirchia SM; Grieco V; Bianchino G; D'Auria F; Statuto T; Mazzoccoli C; De Luca L; Petrucci MT; Morabito F; Offidani M; Di Raimondo F; Falcone A; Caravita T; Omedè P; Boccadoro M; Palumbo A; Neri A
    Am J Hematol; 2013 Jan; 88(1):16-23. PubMed ID: 23044976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA (miRNA) expression profiling of peripheral blood samples in multiple myeloma patients using microarray.
    Yyusnita ; Norsiah ; Zakiah I; Chang KM; Purushotaman VS; Zubaidah Z; Jamal R
    Malays J Pathol; 2012 Dec; 34(2):133-43. PubMed ID: 23424776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
    Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
    Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis.
    Guled M; Lahti L; Lindholm PM; Salmenkivi K; Bagwan I; Nicholson AG; Knuutila S
    Genes Chromosomes Cancer; 2009 Jul; 48(7):615-23. PubMed ID: 19396864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of microRNA-145 down-regulation in adult T-cell leukemia/lymphoma.
    Xia H; Yamada S; Aoyama M; Sato F; Masaki A; Ge Y; Ri M; Ishida T; Ueda R; Utsunomiya A; Asai K; Inagaki H
    Hum Pathol; 2014 Jun; 45(6):1192-8. PubMed ID: 24745613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection.
    Peveling-Oberhag J; Crisman G; Schmidt A; Döring C; Lucioni M; Arcaini L; Rattotti S; Hartmann S; Piiper A; Hofmann WP; Paulli M; Küppers R; Zeuzem S; Hansmann ML
    Leukemia; 2012 Jul; 26(7):1654-62. PubMed ID: 22307176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic aberrations including chromosome 1 abnormalities and clinical features of plasma cell leukemia.
    Chang H; Qi X; Yeung J; Reece D; Xu W; Patterson B
    Leuk Res; 2009 Feb; 33(2):259-62. PubMed ID: 18676019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.
    Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signatures of microRNAs and selected microRNA target genes in human melanoma.
    Philippidou D; Schmitt M; Moser D; Margue C; Nazarov PV; Muller A; Vallar L; Nashan D; Behrmann I; Kreis S
    Cancer Res; 2010 May; 70(10):4163-73. PubMed ID: 20442294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
    Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
    Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide microRNA expression profiling in idiopathic non-obstructive azoospermia: significant up-regulation of miR-141, miR-429 and miR-7-1-3p.
    Wu W; Qin Y; Li Z; Dong J; Dai J; Lu C; Guo X; Zhao Y; Zhu Y; Zhang W; Hang B; Sha J; Shen H; Xia Y; Hu Z; Wang X
    Hum Reprod; 2013 Jul; 28(7):1827-36. PubMed ID: 23559187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptome analysis reveals significant differences between primary plasma cell leukemia and multiple myeloma even when sharing a similar genetic background.
    Rojas EA; Corchete LA; Mateos MV; García-Sanz R; Misiewicz-Krzeminska I; Gutiérrez NC
    Blood Cancer J; 2019 Nov; 9(12):90. PubMed ID: 31748515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential miRNA expression profiles in hepatocellular carcinoma cells and drug-resistant sublines.
    Zhuo L; Liu J; Wang B; Gao M; Huang A
    Oncol Rep; 2013 Feb; 29(2):555-62. PubMed ID: 23229111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent upregulation of MYC in plasma cell leukemia.
    Chiecchio L; Dagrada GP; White HE; Towsend MR; Protheroe RK; Cheung KL; Stockley DM; Orchard KH; Cross NC; Harrison CJ; Ross FM;
    Genes Chromosomes Cancer; 2009 Jul; 48(7):624-36. PubMed ID: 19396865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.
    Zhu DX; Zhu W; Fang C; Fan L; Zou ZJ; Wang YH; Liu P; Hong M; Miao KR; Liu P; Xu W; Li JY
    Carcinogenesis; 2012 Jul; 33(7):1294-301. PubMed ID: 22610076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of microRNAs in basal cell carcinoma.
    Sand M; Skrygan M; Sand D; Georgas D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
    Br J Dermatol; 2012 Oct; 167(4):847-55. PubMed ID: 22540308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes.
    Schepeler T; Holm A; Halvey P; Nordentoft I; Lamy P; Riising EM; Christensen LL; Thorsen K; Liebler DC; Helin K; Ørntoft TF; Andersen CL
    Oncogene; 2012 May; 31(22):2750-60. PubMed ID: 21963845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.